Ideopathic Intracranial Hypertension

Neurosurgery

Volumn 54, Issue 3, 2004, Pages 538-552

  Binder, Devin K ^a   Horton, Jonathan C ^a   Lawton, Michael T ^a   McDermott, Michael W ^a   Dempsey, Robert J ^b   Bergsneider, Marvin ^b   Kelly, Daniel F ^b   Chandler, William F ^b   Selman, Warren R ^b   Grossman, Robert G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Headache; Idiopathic intracranial hypertension; Lumboperitoneal shunt; Optic nerve sheath fenestration; Papilledema; Venous sinus thrombosis; Ventriculoperitoneal shunt

Indexed keywords

ACETAZOLAMIDE; ANTIBIOTIC AGENT; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; DANAZOL; ETHAMBUTOL; ETHYLENE GLYCOL; GROWTH HORMONE; ISOTRETINOIN; LITHIUM; METHANOL; MINOCYCLINE; NALIDIXIC ACID; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOIC ACID; RETINOL; TETRACYCLINE;

BRAIN PSEUDOTUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL DYSPLASIA; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INDUCED DISEASE; ELECTROLYTE DISTURBANCE; HEADACHE; HUMAN; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; LIMB MALFORMATION; LUMBAR PUNCTURE; LUMBOPERITONEAL SHUNT; METABOLIC ACIDOSIS; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE SHEATH FENESTRATION; PAPILLEDEMA; PATIENT COUNSELING; PHLEBOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TERATOGENICITY; TREATMENT PLANNING; WEIGHT REDUCTION; COMPARATIVE STUDY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HUMANS; INTRACRANIAL HYPERTENSION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK FACTORS;

EID: 3442882824     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000109042.87246.3C     Document Type: Review

References (200)

1. Ahlskog JE, O'Neill BP: Pseudotumor cerebri. Ann Intern Med 97:249-256, 1982.
2. Baker RS, Carter D, Hendrick EB, Buncic JR: Visual loss in pseudotumor cerebri of childhood: A follow-up study. Arch Ophthalmol 103:1681-1686, 1985.
3. Banta JT, Farris BK: Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 107:1907-1912, 2000.
4. Bartynski WS, Valliappan S, Uselman JH, Spearman MP: The adult radiographic shuntogram. AJNR Am J Neuroradiol 21:721-726, 2000.
5. Bedford THB: The effect of increased intracranial venous pressure on the pressure of the cerebrospinal fluid. Brain 58:427-447, 1935.
6. + channels. Reprod Toxicol 11:823-831, 1997.
7. Billson FA, Hudson RL: Surgical treatment of chronic papilledema in children. Br J Ophthalmol 59:92-95, 1975.
8. Biousse V, Newman NJ, Lessell S: Audible pulsatile tinnitus in idiopathic intracranial hypertension. Neurology 50:1185-1186, 1998.
9. Birdwell BG, Yeager R, Whitsett TL: Pseudotumor cerebri: A complication of catheter-induced subclavian vein thrombosis. Arch Intern Med 154: 808-811, 1994.
10. Blaw ME: Associated and idiopathic intracranial hypertension in children. Postgrad Med 50:191-195, 1971.
11. Bousser MG: Cerebral venous thrombosis: Diagnosis and management. J Neurol 247:252-258, 2000.
12. Brazis PW, Lee AG: Elevated intracranial pressure and pseudotumor cerebri. Curr Opin Ophthalmol 9:27-32, 1998.
13. Brockmeier B, Burbach H, Runge M, Altenkirch H: Raised intracranial pressure in chronic respiratory disease. Lancet 349:883, 1997 (letter).
14. Brodsky MC, Vaphiades M: Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 105:1686-1693, 1998.
15. Brourman ND, Spoor TC, Ramocki JM: Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 106:1378-1383, 1988.
16. Burde RM, Karp JS, Miller RN: Reversal of visual deficit with optic nerve decompression in long-standing pseudotumor cerebri. Am J Ophthalmol 77:770-771, 1984.
17. Burgett RA, Purvin VA, Kawasaki A: Lumboperitoneal shunting for pseudotumor cerebri. Neurology 49:734-739, 1997.
18. Campos SP, Olitsky S: Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism. Clin Pediatr 34:334-337, 1995.
19. Cantu C, Barinagarrementeria F: Cerebral venous thrombosis associated with pregnancy and puerperium: Review of 67 cases. Stroke 24:1880-1884, 1993.
20. Capobianco DJ, Brazis PW, Cheshire WP: Idiopathic intracranial hypertension and seventh nerve palsy. Headache 37:286-288, 1997.
21. Capriles LF: Intracranial hypertension and iron-deficiency anemia. Arch Neurol 9:147-153, 1963.
22. Carlow TJ, Glaser JS: Pseudotumor cerebri syndrome in systemic lupus erythematosus. JAMA 228:197-200, 1974.
23. Chang D, Nagamoto G, Smith WE: Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 59:419-422, 1992.
24. Ch'ien LT: Intracranial hypertension and sulfamethoxazole. N Engl J Med 283:47, 1976 (letter).
25. Chiu AM, Chuenkongkaew WL, Comblath WT, Trobe JD, Digre KB, Dotan SA, Musson KH, Eggenberger ER: Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 126:116-121, 1998.
26. Chumas PD, Armstrong DC, Drake JM, Kulkami AV, Hoffman HJ, Humphreys RP, Rutka JT, Hendrick EB: Tonsillar herniation: The rule rather than the exception after lumboperitoneal shunting in the pediatric population. J Neurosurg 78:568-573, 1993.
27. Chumas PD, Kulkarni AV, Drake JM, Hoffman HJ, Humphreys RP, Rutka JT: Lumboperitoneal shunting: A retrospective study in the pediatric population. Neurosurgery 32:376-383, 1993.
28. Chutarian AM, Gold AP, Braun CN: Benign intracranial hypertension and Bell's palsy. N Engl J Med 296:1214-1215, 1977.
29. Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ: Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry 65:308-316, 1998.
30. Cohen DN: Intracranial hypertension and papilledema associated with nalidixic acid. Am J Ophthalmol 76:680-682, 1973.
31. Comabella M, Montalban J, Lozano M, Codina A: Lhermitte's sign in pseudotumor cerebri. J Neurol 242:610-611, 1995.
32. Condulis N, Germain G, Charest N, Levy S, Carpenter TO: Pseudotumor cerebri: A presenting manifestation of Addison's disease. Clin Pediatr 36:711-713, 1997.
33. Corbett JJ: Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 10:221-229, 1983.
34. Corbett JJ, Thompson HS: The rational management of idiopathic intracranial hypertension. Arch Neurol 46:1049-1051, 1989.
35. Corbett JJ, Nerad JA, Tse DT, Anderson RL: Results of optic nerve sheath fenestration for pseudotumor cerebri: The lateral orbitotomy approach. Arch Ophthalmol 106:1391-1397, 1988.
36. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, Hopson D: Visual loss in pseudotumor cerebri: Follow-up of 57 patients from 5 to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 39:461-474, 1982.
37. Couban S, Maxner CE: Cerebral venous sinus thrombosis presenting as idiopathic intracranial hypertension. Can Med Assoc J 145:657-659, 1991.
38. Cushing H, Noleson A: Notes on a series of intracranial tumor and conditions simulating them: Tumor suspects; tumors unverified; tumors verified. Arch Neurol Psych 10:605-668, 1923.
39. Dandy WE: Intracranial pressure without brain tumor: Diagnosis and treatment. Ann Surg 106:492-513, 1937.
40. Davidoff LM, Dyke CG: Hypertensive meningeal hydrops: A syndrome frequently following infection in the middle ear or elsewhere in the body. Am J Ophthalmol 20:908-927, 1937.
41. Davidson SI: A surgical approach to plerocephalic disc edema. Trans Ophthalmol Soc U K 89:669-690, 1969.
42. Davies G, Zilkha KJ: Decompression of the optic nerve in benign intracranial hypertension. Trans Ophthalmol Soc U K 96:427-429, 1976.
43. de Wecker L: On incision of the optic nerve in cases of neuroretinitis, in Fourth International Ophthalmological Congress: August, 1872. London, Savill Edwards, 1873, pp 11-14.
44. Digre KB, Corbett JJ: Idiopathic intracranial hypertension (pseudotumor cerebri): A reappraisal. Neurology 7:2-67, 2001.
45. Deleted in proof.
46. Donaldson JO: Pathogenesis of pseudotumor cerebri syndromes. Neurology 31:877-880, 1981.
47. Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri: Population studies in Iowa and Louisiana. Arch Neurol 45:875-877, 1988.
48. Eggenberger ER, Miller NR, Vitale S: Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 46:1524-1530, 1996.
49. Eisenberg HM, McComb JG, Lorenzo AV: Cerebrospinal fluid overproduction and hydrocephalus associated with choroid plexus papilloma. J Neurosurg 40:381-385, 1974.
50. Fischer EG, Welch K, Shillito J: Syringomyelia following lumboperitoneal shunting for communicating hydrocephalus: Report of three cases. J Neurosurg 47:96-100, 1977.
51. Fishman RA: The pathophysiology of pseudotumor cerebri: An unsolved puzzle. Arch Neurol 41:257-258, 1984.
52. Fishman RA: Cerebrospinal Fluid in Diseases, of the Nervous System, Philadelphia, W.B. Saunders Co., 1992.
53. Foley J: Benign forms of intracranial hypertension: "Toxic" and "otitic" hydrocephalus. Brain 78:1-41, 1955.
54. Fujiwara S, Sawamura Y, Kato T, Abe H, Katusima H: Idiopathic intracranial hypertension in female homozygous twins. J Neurol Neurosurg Psychiatry 62:652-654, 1997.
55. Galbraith JEK, Sullivan JH: Decompression of the perioptic meninges for relief of papilledema. Am J Ophthalmol 76:687-692, 1973.
56. Gardner K, Cox T, Digre KB: Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: Case reports and review. Neurology 45:6-10, 1995.
57. Gass A, Barker GJ, Riordan-Eva P, MacManus D, Sanders M, Tofts PS, McDonald WI, Moseley IF, Miller DH: MRI of the optic nerve in benign intracranial hypertension. Neuroradiology 38:769-773, 1996.
58. Getenet JC, Croisile B, Vighetto A, Grochowicki M, Goudable B, Aimard G, Trillet M: Idiopathic intracranial hypertension after ofloxacin treatment. Acta Neurol Scand 87:503-504, 1993.
59. Gettelfinger DM, Komen E: Superior sagittal sinus thrombosis. Arch Neurol 34:2-6, 1977.
60. Gideon P, Sorensen PS, Thomsen C, Stahlberg F, Gjerris F, Henriksen O: Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol 16:381-387, 1995.
61. Giles C, Soble A: Intracranial hypertension and tetracycline therapy. Am J Ophthalmol 72:981-982, 1971.
62. Giuseffi V, Wall M, Siegel PZ, Rojas PB: Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology 41:239-244, 1991.
63. Goh KY, Schatz NJ, Glaser JS: Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol 17:86-91, 1997.
64. Greer M: Benign intracranial hypertension: Part I-Mastoiditis and lateral sinus obstruction. Neurology 12:472-476, 1961.
65. Greer M: Management of benign intracranial hypertension (pseudotumor cerebri). Clin Neurosurg 15:161-174, 1968.
66. Guy J, Johnston PK, Corbett JJ, Day AL, Glaser JS: Treatment of visual loss in pseudotumor cerebri associated with uremia. Neurology 40:28-32, 1990.
67. Halbach VV, Hieshima GB, Higashida RT, Reicher M: Carotid cavernous fistulae: Indications for urgent treatment. AJR Am J Roentgenol 149:587-593, 1987.
68. Hamed LM, Glaser JS, Schatz NJ, Perez TH: Pseudotumor cerebri induced by danazol. Am J Ophthalmol 107:105-110, 1989.
69. Hannerz J, Greitz D, Ericson K: Is there a relationship between obesity and intracranial hypertension? Int J Obes Relat Metab Disord 19:240-244, 1995.
70. Hart A, David K, Powell M: The treatment of "acquired tonsillar herniation" in pseudoturnor cerebri. Br J Neurosurg 14:563-565, 2000.
71. Herzau V, Baykal HE: Long-term outcome of optic nerve sheath fenestration in pseudotumor cerebri [in German]. Klin Monatsbl Augenheilkd 213:154-160, 1998.
72. Horton JC, Seiff SR, Pitts LH, Weinstein PR, Rosenblum ML, Hoyt WF: Decompression of the optic nerve sheath for vision-threatening papilledema caused by dural sinus occlusion. Neurosurgery 31:203-212, 1992.
73. Howman-Giles R, Uren RG, Johnston I: Cerebrospinal fluid physiology, clearance flow studies, and cerebrospinal fluid shunt studies, in Murray IPC, Ell PJ (eds): Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh, Churchill Livingstone, 1998.
74. Huseman CA, Torkelson RD: Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism. Am J Dis Child 138:927-931, 1984.
75. Ingraham FD, Sears RA, Woods RP, Bailey OT: Further studies on the treatment of experimental hydrocephalus. J Neurosurg 6:207-215, 1949.
76. Ischemic Optic Neuropathy Decompression Trial Research Group: Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful: The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 273:625-632, 1995.
77. Jacobson DM, Karanjia PN, Olson KA, Warner JJ: Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 40:1454-1455, 1990.
78. Janny P, Chazal J, Colnet G, Irthum B, Georget AM: Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 15:168-174, 1981.
79. Jennum P, Borgesen SE: Intracranial pressure and obstructive sleep apnea. Chest 95:279-283, 1989.
80. Johnson LN, Krohel GB, Madsen RW, March GA: The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105:2313-2317, 1998.
81. Johnston I, Morgan MK: A familial coincidence of pseudotumor cerebri and communicating hydrocephalus. Neurosurgery 28:727-729, 1991.
82. Johnston I, Patterson A: Benign intracranial hypertension: Part II-CSF pressure and circulation. Brain 97:301-312, 1974.
83. Johnston I, Besser M, Morgan MK: Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 69:195-202, 1988.
84. Johnston I, Hawke S, Halmagyi M, Teo C: The pseudotumor syndrome: Disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly. Arch Neurol 48:740-747, 1991.
85. Johnston I, Paterson A, Besser M: The treatment of benign intracranial hypertension: A review of 134 cases. Surg Neurol 16:218-224, 1981.
86. Kaaber EG, Zilstorff K: Vestibular function in benign intracranial hypertension. Clin Otolaryngol 3:183-188, 1978.
87. Kang S: Efficacy of lumbo-peritoneal versus ventriculo-peritoneal shunting for management of chronic hydrocephalus following aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 142:45-49, 2000.
88. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ: Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46:198-202, 1996.
89. Katz DM, Trobe JD, Muraszko KM, Dauser RC: Shunt failure without ventriculomegaly proclaimed by ophthalmic findings. J Neurosurg 81: 721-725, 1994.
90. Kaye AH, Galbraith JEK, King J: Intracranial pressure following optic nerve decompression for benign intracranial hypertension. J Neurosurg 55:453-456, 1981.
91. Kiers L, King JO: Increased intracranial pressure following bilateral neck dissection and radiotherapy. Aust N Z J Surg 61:459-461, 1991.
92. Krishna R, Kosmorsky GS, Wright KW: Pseudotumor cerebri sine papilledema with unilateral sixth nerve palsy. J Neuroophthalmol 18:53-55, 1998.
93. Kulkarni AV, Chumas PD, Drake JM, Armstrong DC: The reliability of the "absent cistern sign" in assessing LP shunt function. Can J Neurol Sci 26:40-43, 1999.
94. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M: Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50:1094-1098, 1998.
95. Lam BL, Schatz NJ, Glaser JS, Bowen BC: Pseudotumor cerebri from cranial venous obstruction. Ophthalmology 99:706-712, 1992.
96. Lee AG: Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 55:165-168, 1995.
97. Leker RR, Steiner I: Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 55:817-820, 1998.
98. Leker RR, Steiner I: Features of dural sinus thrombosis simulating pseudotumor cerebri. Eur J Neurol 6:601-604, 1999.
99. Lepore FE: Unilateral and highly asymmetric papilledema in pseudotumor cerebri. Neurology 42:676-678, 1992.
100. Levine SH, Puchalski C: Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 51:251-253, 1990.
101. Li EK, Ho PC: Pseudotumor cerebri in systemic lupus erythematosus. J Rheumatol 16:113-116, 1989.
102. Lipton HL, Michelson PE: Pseudotumor cerebri syndrome without papilledema. JAMA 220:1591-1592, 1972.
103. Liu GT, Glaser JS, Schatz NJ: High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 118:88-96, 1994.
104. Ludemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, Assmann G, Ringelstein EB: Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: A case control study of 55 patients. Stroke 29:2507-2510, 1998.
105. Marcelis J, Silberstein SD: Idiopathic intracranial hypertension without papilledema. Arch Neurol 48:392-399, 1991.
106. Marr WG, Chambers RG: Pseudotumor cerebri syndrome: Following unilateral radical neck dissection. Am J Ophthalmol 51:605-611, 1961.
107. Marr WG, Chambers JW: Occlusion of the cerebral dural sinuses by tumor simulating pseudotumor cerebri. Am J Ophthalmol 61:45-49, 1966.
108. Mathew NT, Ravishankar K, Sanin LC: Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46: 1226-1230, 1996.
109. Matson DD: A new operation for the treatment of communicating hydrocephalus. J Neurosurg 6:238-247, 1949.
110. McAlpine D: Toxic hydrocephalus. Brain 60:180-203, 1937.
111. McNamara ME: Idiopathic intracranial hypertension without papilledema: Related to sleep apnea? Arch Neurol 49:14, 1992 (letter).
112. Meador KJ, Swift TR: Tinnitus from intracranial hypertension. Neurology 34:1258-1261, 1984.
113. Merlob P, Litwin A, Mor N: Possible association between acetazolamide administration during pregnancy and metabolic disorders in the newborn. Eur J Obstet Gynecol Reprod Biol 35:85-88, 1990.
114. Minutello JS, Dimayuga RG, Carter J: Pseudotumor cerebri, a rare adverse reaction to tetracycline therapy: A case report. J Periodontol 59:848-851, 1988.
115. a. Mochizuki K, Takahashi T, Kano M, Terajima K, Hori N: Pseudotumor cerebri induced by minocycline therapy for acne vulgaris. Jpn J Ophthalmol 46:668-672, 2002.
116. Mokri B: The Monro-Kellie hypothesis: Applications in CSF volume depletion. Neurology 56:1746-1748, 2001.
117. Mokri B, Jack CR, Petty GW: Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies. Stroke 24:469-472, 1993.
118. Morrice G: Papilledema and hypervitaminosis A. JAMA 213:1344, 1970 (letter).
119. Morrice G, Havener WH, Kapetanxky F: Vitamin A intoxication as a cause of pseudotumor cerebri. JAMA 173:1802-1805, 1960.
120. Moser FG, Hilal SK, Abrams G, Bello JA, Schipper H, Silver AJ: MR imaging of pseudotumor cerebri. AJR Am J Roentgenol 150:903-909, 1988.
121. Murphy TP: Otologic manifestations of pseudotumor cerebri. J Otolaryngol 20:258-261, 1991.
122. Naderi S, Nukala S, Marruenda F, Kudarvalli P, Koduri PR: Pseudotumour cerebri in acute promyelocytic leukemia: Improvement despite continued ATRA therapy. Ann Hematol 78:333-334, 1999.
123. Neville BGR, Wilson J: Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J 3:554-556, 1970.
124. Noetzel MJ, Rioux SD: Pseudotumor cerebri associated with obstructive nephropathy. Pediatr Neurol 2:238-240, 1986.
125. Nonne M: Über Falle vom Symptomenkomplex "Tumor Cerebri" mit Ausgang in Heilun (Pseudotumor Cerebri): Über letal verlaufene Falle von "Pseudotumor Cerebri" mit Sektionsbefund. Deutsche Zeitschr für Nerven Heilkunde 27:169-216, 1904.
126. Owler BK, Parker G, Halmagyi GM, Dunne VG, Grinnell V, McDowell D, Besser M: Pseudotumor cerebri syndrome: Venous sinus obstruction and its treatment with stent placement. J Neurosurg 98:1045-1055, 2003.
127. Ozawa H, Azuma E, Shindo K, Higashigawa M, Mukouhara R, Komada Y: Transient renal tubular acidosis in a neonate following transplacental acetazolamide. Eur J Pediatr 160:321-322, 2001.
128. Padeh S, Passwell JH: Systemic lupus erythematosus presenting as idiopathic intracranial hypertension. J Rheumatol 23:1266-1268, 1996.
129. Pasquale LR, Moster ML, Schmaier A: Dural sinus thrombosis with abnormalities of protein S and fibrinogen. Arch Ophthalmol 108:644, 1990.
130. Pierog SH, Al-Salihi FL, Cinotti D: Pseudotumor cerebri: A complication of tetracycline treatment of acne. J Adolesc Health Care 7:139-140, 1986.
131. Plotnik JL, Kosmorsky GS: Operative complications of optic nerve sheath decompression. Ophthalmology 100:683-690, 1993.
132. Quincke H: Über Meningitis serosa: Sammlung linische Vortra 67. Inn Med 23:655-694, 1893.
133. Quincke H: Über Meningitis serosa und verwandte Zustande. Deutsche Z Nervenheilk 25:85-88, 1897.
134. Radhakrishnan K, Sridharan R, Ashok PP, Mousa ME: Pseudotumour cerebri: Incidence and pattern in North-Eastern Libya. Eur Neurol 25:117-124, 1986.
135. Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE: Epidemiology of idiopathic intracranial hypertension: A prospective and case-control study. J Neurol Sci 116:18-28, 1993.
136. Raghavan S, DiMartino-Nardi J, Saenger P, Linder B: Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 130:478-480, 1997.
137. Raichle ME, Grubb RL Jr, Phelps ME, Gado MH, Caronna JJ: Cerebral hemodynamics and metabolism in pseudotumor cerebri. Ann Neurol 4:104-111, 1978.
138. Ray BS, Dunbar HS: Thrombosis of the dural venous sinus as a cause of pseudotumor cerebri. Ann Surg 134:376-386, 1951.
139. Reid AC, Matheson MS, Teasdale G: Volume of the ventricles in benign intracranial hypertension. Lancet 2:7-8, 1980.
140. Rish BL, Meacham WF: Pseudotumor cerebri: A historical and clinical review. J Tenn Med Assoc 58:355-361, 1965.
141. Rogers AH, Rogers GL, Bremer DL, McGregor ML: Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 106:1186-1190, 1999.
142. Rosenberg ML, Corbett JJ, Smith C, Goodwin J, Sergott R, Savino P, Schatz N: Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 43:1071-1072, 1993.
143. Rothner AD, Brust JC: Pseudotumor cerebri: Report of a familial occurrence. Arch Neurol 30:110-111, 1974.
144. Rottenberg DA, Foley KM, Posner JB: Hypothesis: The pathogenesis of pseudotumor cerebri. Med Hypotheses 6:913-918, 1980.
145. Roytman M, Frumkin A, Bohn TG: Pseudotumor cerebri caused by isotretinoin. Cutis 42:399-400, 1988.
146. Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rall DP: The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg 25:430-436, 1966.
147. Rush JA: Pseudotumor cerebri: Clinical profile and visual outcome in 63 patients. Mayo Clin Proc 55:541-546, 1980.
148. Sahs AL, Joynt RJ: Brain swelling of unknown cause. Neurology 6:791-803, 1956.
149. Saini JS, Jain IS, Dhar S, Mohan K: Uremic optic neuropathy. J Clin Neuroophthalmol 9:131-133, 1989.
150. Santinelli R, Tolone C, Toraldo R, Canino G, De Simone A, D'Avanzo M: Familial idiopathic intracranial hypertension with spinal and radicular pain. Arch Neurol 55:854-856, 1998.
151. Saul RF, Hamburger HA, Selhorst JB: Pseudotumor cerebri secondary to lithium carbonate. JAMA 253:2869-2870, 1985.
152. Scott WJ, Schreiner CM, Hirsch KS: Unique pattern of limb malformations associated with carbonic anhydrase inhibition. Prog Clin Biol Res 110: 423-429, 1983.
153. Seiff SR, Shah L: A model for the mechanism of optic nerve sheath fenestration. Arch Ophthalmol 108:1326-1329, 1990.
154. Selky AK, Dobyns WB, Yee RD: Idiopathic intracranial hypertension and facial diplegia. Neurology 44:357, 1994.
155. Selman WR, Spetzler RF, Wilson CB, Grollmus JW: Percutaneous lumboperitoneal shunt: Review of 130 cases. Neurosurgery 6:255-257, 1980.
156. Sergott RC: Optic nerve sheath decompression: History, techniques, and indications. Int Ophthalmol Clin 31:71-81, 1991.
157. Sergott RC, Cohen MS, Bosley TM, Savino PJ: Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol 107:1743-1754, 1989.
158. Sergott RC, Savino PJ, Bosley TM: Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 106:1384-1390, 1988.
159. Shapiro I, Shapiro SK: Familial pseudotumor cerebri and the empty sella syndrome. Ann Ophthalmol 12:1045-1048, 1980.
160. Shapiro K, Marmarou A, Shulman K: Characterization of clinical CSF dynamics and neural axis compliance using the pressure-volume index. Ann Neurol 7:508-514, 1980.
161. Sher NA, Wirtschafter J, Shapiro SK, See C, Shapiro I: Unilateral papilledema in "benign" intracranial hypertension (pseudotumor cerebri). JAMA 250:2346-2347, 1983.
162. Sherman GF, Holmes LB: Cerebrocortical microdysgenesis is enhanced in c57BL/6J mice exposed in utero to acetazolamide. Teratology 60:137-142, 1999.
163. Shulman K, Ransohoff J: Sagittal sinus venous pressure in hydrocephalus. J Neurosurg 23:169-173, 1965.
164. Sismanis A: Otologic manifestations of benign intracranial hypertension syndrome: Diagnosis and management. Laryngoscope 97:1-17, 1987.
165. Sismanis A, Butts FM, Hughes GB: Objective tinnitus in benign intracranial hypertension: An update. Laryngoscope 100:33-36, 1990.
166. Sismanis A, Hughes GB, Abedi E, Williams GH, Isrow LA: Otologic symptoms and findings of the pseudotumor cerebri syndrome: A preliminary report. Otolaryngol Head Neck Surg 93:398-402, 1985.
167. Sklar FH, Beyer CW Jr, Ramanathan M, Cooper PR, Clark WK: Cerebrospinal fluid dynamics in patients with pseudotumor cerebri. Neurosurgery 5:208-216, 1979.
168. Smith JL: Whence pseudotumor cerebri? J Clin Neuroophthalmol 5:55-56, 1985.
169. Sorensen PS, Thomsen C, Gjerris F, Henriksen O: Brain water accumulation in pseudotumour cerebri demonstrated by MR-imaging of brain water self-diffusion. Acta Neurochir Suppl (Wien) 51:363-365, 1990.
170. Sorensen PS, Thomsen C, Gjerris F, Schmidt J, Kjaer L, Henriksen O: Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self diffusion. Neurol Res 11:160-164, 1989.
171. Spector RH, Carlisle J: Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 34:1509-1511, 1984.
172. Spetzler RF, Wilson CB, Grollmus JM: Percutaneous lumboperitoneal shunt: Technical note. J Neurosurg 43:770-773, 1975.
173. Spoor TC, McHenry JG: Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 111:632-635, 1993.
174. Spoor TC, Ramocki JM, Madion MP, Wilkinson MJ: Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol 112:177-185, 1991.
175. Sugerman HJ, DeMaria EJ, Felton WL, Nakatsuka M, Sismanis A: Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 49:507-511, 1997.
176. Sugerman HJ, Felton WL, Salvant JB Jr, Sismanis A, Kellum JM: Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 45:1655-1659, 1995.
177. Sugerman HJ, Felton WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL: Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 229:634-642, 1999.
178. Sunku AJ, O'Duffy AE, Swanson JW: Benign intracranial hypertension associated with levonorgestrel implants. Ann Neurol 34:299, 1993 (abstr).
179. Symonds CP: Otitic hydrocephalus. Brain 54:55-71, 1931.
180. Theodosopoulos PV, Abosch A, McDermott MW: Intraoperative fiber-optic endoscopy for ventricular catheter insertion. Can J Neurol Sci 28:56-60, 2001.
181. To KW, Warren FA: Unilateral papilledema in pseudotumor cerebri. Arch Ophthalmol (Paris) 108:644-645, 1990.
182. Torlai F, Galassi G, Debbia A, Crisi G, Peduzzi M: Familial pseudotumor cerebri in male heterozygous twins. Eur Neurol 29:106-108, 1989.
183. Tulipan N, Lavin PJ, Copeland M: Stereotactic ventriculoperitoneal shunt for idiopathic intracranial hypertension: Technical note. Neurosurgery 43:175-177, 1998.
184. Vander Ark GD, Kempe LG, Smith DR: Pseudotumor cerebri treated with lumbar-peritoneal shunt. JAMA 217:1832-1834, 1971.
185. Vijayan N: Postoperative headache in acoustic neuroma. Headache 35:98-100, 1995.
186. Visani G, Bontempo G, Manfroi S, Pazzaglia A, D'Alessandro R, Tura S: All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: A possible disease association. Haematologica 81:152-154, 1996.
187. Visani G, Manfroi S, Tosi P, Martinelli G: All-trans-retinoic acid and pseudotumor cerebri. Leuk Lymphoma 23:437-442, 1996.
188. Wall M: The headache profile of idiopathic intracranial hypertension. Cephalalgia 10:331-335, 1990.
189. Wall M: Idiopathic intracranial hypertension. Neurol Clin 9:73-95, 1991.
190. Wall M, George D: Idiopathic intracranial hypertension: A prospective study of 50 patients. Brain 114:155-180, 1991.
191. Wall M, Dollar JD, Sadun AA, Kardon R: Idiopathic intracranial hypertension: Lack of histologic evidence for cerebral edema. Arch Neurol 52:141-145, 1995.
192. Walsh FB, Clark DB, Thompson RS, Nicholson DH: Oral contraceptives and neuro-ophthalmologic interest. Arch Ophthalmol 74:628-640, 1965.
193. Wang SJ, Silberstein SD, Patterson S, Young WB: Idiopathic intracranial hypertension without papilledema: A case-control study in a headache center. Neurology 51:245-249, 1998.
194. Wasan H, Mansi JL, Benjamin S, Powles R, Cunningham D: Myeloma and benign intracranial hypertension. BMJ 304:685, 1992.
195. Weih M, Vetter B, Ziemer S, Mehraein S, Valdueza JM, Koscielny J, Kulozik AE, Einhaupl KM: Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol 245:149-152, 1998.
196. Weisberg LA: Benign intracranial hypertension. Medicine 54:197-207, 1975.
197. Welch K, Shillito J, Strand R, Fischer EG, Winston KR: Chiari I "malformations": An acquired disorder? J Neurosurg 55:604-609, 1981.
198. Wessel K, Thron A, Linden D, Petersen D, Dichgans J: Pseudotumor cerebri: Clinical and neuroradiological findings. Eur Arch Psychiatry Neurol Sci 237:54-60, 1987.
199. Winner P, Bello L: Idiopathic intracranial hypertension in a young child without visual symptoms or signs. Headache 36:574-576, 1996.
200. Winrow AP, Supramaniam G: Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 65:1165-1166, 1990.